Ribon Therapeutics Patents – Insights & Stats (Updated 2023)

Ribon Therapeutics has a total of 132 patents globally, out of which 34 have been granted. Of these 132 patents, more than 93% patents are active. United States of America is where Ribon Therapeutics has filed the maximum number of patents, followed by Taiwan and Europe. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Ribon Therapeutics.

Ribon Therapeutics was founded in the year 2015. The Company operates as a biotechnology company. The Company discovers and develops new cancer medicines and drugs for the treatment of cancer diseases.

Do read about some of the most popular patents of Ribon Therapeutics which have been covered by us in this article and also you can find Ribon Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Ribon Therapeutics patent portfolio.

How many patents does the founder and the CEO of Ribon Therapeutics have?

The founder Paul Chang has 0 patent and CEO Prakash Raman has 0 patent.

How many patents does Ribon Therapeutics have?

Ribon Therapeutics has a total of 132 patents globally. These patents belong to 15 unique patent families. Out of 132 patents, 124 patents are active.

How Many Patents did Ribon Therapeutics File Every Year?

Ribon Therapeutics Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantRibon Therapeutics Applications FiledRibon Therapeutics Patents Granted
2023324
2022202
202164
2020474
201931
201825

How many Ribon Therapeutics patents are Alive/Dead?

Ribon Therapeutics Patent Portfolio

 How Many Patents did Ribon Therapeutics File in Different Countries?

Ribon Therapeutics Worldwide Patent Filing

Countries in which Ribon Therapeutics Filed Patents

CountryPatents
United States Of America15
Taiwan7
Europe7
Japan6
Australia5
Argentina5
Canada5
Mexico5
India5
Hong Kong (S.A.R.)4
Israel4
Brazil4
South Africa4
Singapore3
New Zealand3
Finland2
Portugal2
Austria2
Croatia2
Serbia2
Norway2
Slovenia2
Indonesia2
Poland2
Viet Nam2
Lithuania2
Denmark2
Morocco2
Italy2
Peru1
Costa Rica1
Ecuador1
Colombia1
Chile1
Spain1
Philippines1
Malaysia1
Hungary1
Slovakia1

Where are Research Centres of Ribon Therapeutics Patents Located?

R&D Centers of Ribon Therapeutics

 10 Best Ribon Therapeutics Patents

WO2019212937A1 is the most popular patent in the Ribon Therapeutics portfolio. It has received 18 citations so far from companies like Pipeline Therapeutics, Jacobio Pharmaceuticals and Gilead Sciences.

Below is the list of 10 most cited patents of Ribon Therapeutics:

Publication NumberCitation Count
WO2019212937A118
WO2021087018A117
WO2021087025A115
WO2020223229A112
US10550105B28
US11014913B24
US10870641B24
WO2021021986A14
US11293927B22
US10562891B22

What Percentage of Ribon Therapeutics US Patent Applications were Granted?

Ribon Therapeutics (Excluding its subsidiaries) has filed 13 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 5 have been granted leading to a grant rate of 100.0%.

Below are the key stats of Ribon Therapeutics patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Ribon Therapeutics?

Law FirmTotal ApplicationsSuccess Rate
Fish & Richardson13100.00%

What are Ribon Therapeutics key innovation segments?

What Technologies are Covered by Ribon Therapeutics?

The chart below distributes patents filed by Ribon Therapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where Ribon Therapeutics thinks it’s important to protect particular technology inventions.

R&D Focus: How has Ribon Therapeutics search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Ribon Therapeutics?

Related Articles

VoxelSensors Patents – Insights & Stats (Updated 2024)

VoxelSensors has a total of 36 patents globally, out of which 8 have been granted. Of these 36 patents, more than 94% patents are active. Europe (EPO) is where VoxelSensors has filed the maximum number of patents, followed by China and Israel. Parallelly, Belgium seems to be the main focused

Read More »

Alphapharm Patents – Insights & Stats (Updated 2024)

Alphapharm has a total of 108 patents globally, out of which 43 have been granted. Of these 108 patents, more than 18% patents are active. Australia is where Alphapharm has filed the maximum number of patents, followed by Europe (EPO) and United States of America. Parallelly, Australia seems to be

Read More »

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.